Sheraz Ahmad Bhat
Overview
Explore the profile of Sheraz Ahmad Bhat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdullah E, Khan M, Aziz I, Alokail M, Karthikeyan S, Rupavarshini M, et al.
Int J Biol Macromol
. 2024 Sep;
279(Pt 4):135458.
PMID: 39251007
L-asparaginase is a remarkable antineoplastic enzyme used in medicine for the treatment of acute lymphoblastic leukemia (ALL) as well as in food industries. In this work, the L-asparaginase-II gene from...
2.
Khan M, Bhat S, Saud Albagmi M, Arshad M, Tarique M, Bano B
Saudi Pharm J
. 2024 Jan;
32(1):101916.
PMID: 38178850
Glycation is the non-enzymatic adduct formation between reducing sugars or dicarbonyls with proteins and is a crucial molecular event under hyperglycaemic conditions of diabetes. The accumulation of advanced glycation end...
3.
Bhat S, Farooq Z, Ismail H, Corona-Avila I, Khan M
Technol Cancer Res Treat
. 2023 Dec;
22:15330338231219434.
PMID: 38083797
Hepatocellular carcinoma (HCC) is the primary form of liver cancer. It causes ∼ 800 000 deaths per year, which is expected to increase due to increasing rates of obesity and...
4.
Farooq Z, Ismail H, Bhat S, Layden B, Khan M
Life (Basel)
. 2023 Apr;
13(4).
PMID: 37109475
Hexokinases (HKs) convert hexose sugars to hexose-6-phosphate, thus trapping them inside cells to meet the synthetic and energetic demands. HKs participate in various standard and altered physiological processes, including cancer,...
5.
Khan M, Alomari A, Tabrez S, Hassan I, Wahab R, Bhat S, et al.
Pharmaceutics
. 2021 Jun;
13(5).
PMID: 34066092
The continuous loss of human life due to the paucity of effective drugs against different forms of cancer demands a better/noble therapeutic approach. One possible way could be the use...
6.
Khan M, Tabrez S, Al-Okail M, Shaik G, Bhat S, Rehman T, et al.
J Biomol Struct Dyn
. 2020 Jan;
39(3):777-786.
PMID: 31960772
Methylglyoxal (MG) is a potent glycating agent which reacts with proteins to form advanced glycation end products (AGEs). These chemically stable AGEs crosslink with proteins and could lead to amyloid...
7.
Khan M, Rehman M, Bhat S, Tabrez S, Hussain A, Husain F, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2019 Feb;
214:216-226.
PMID: 30785041
Protein aggregation leads to vast conformational changes and plays a key role in the pathogenesis of various neurodegenerative diseases including Alzheimer's and Parkinson's. In the current piece of work, we...
8.
Khan M, Bhat S, Rehman M, Hassan I, Tabrez S, Alajmi M, et al.
Int J Biol Macromol
. 2018 Aug;
120(Pt A):45-58.
PMID: 30081131
Amyloid fibrils are highly ordered protein assemblies known to contribute to the pathology of a variety of genetic and aging-associated diseases. Here, we have investigated the aggregation propensity of lysozyme...
9.
Bhat S, Bhat W, Arif H, Afsar M, Sohail A, Khan M, et al.
Biochim Biophys Acta Proteins Proteom
. 2018 Jul;
1866(9):989-1000.
PMID: 29964207
Hyperglycaemic conditions facilitate the glycation of serum proteins which may have predisposition to aggregation and thus lead to complications. The current study investigates the glycation induced structural and functional modifications...
10.
Bhat S, Bhat W, Afsar M, Khan M, Al-Bagmi M, Bano B
Arch Biochem Biophys
. 2018 May;
650:103-115.
PMID: 29775569
Reactive dicarbonyl species such as methylglyoxal (MGO) and glyoxal (GO) have recently received extensive attention due to their high reactivity and ability to modify biological substances such as proteins, phospholipids,...